PTPRD/PTPRT mutation as a predictive biomarker of immune checkpoint inhibitors across multiple cancer types

BACKGROUND: Immune checkpoint inhibitors (ICIs) are dramatically changing the treatment landscape of a variety of cancers. Nevertheless, the variability in ICI responses highlight the importance in identifying predictive biomarkers. PTPRD and PTPRT (PTPRD/PTPRT) are the phosphatases of JAK-STAT sign...

Descripción completa

Detalles Bibliográficos
Autores principales: Shang, Xiaoling, Zhang, Wengang, Zhang, Xun, Yu, Miao, Liu, Jingwen, Cheng, Yufeng, Cheng, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556668/
https://www.ncbi.nlm.nih.gov/pubmed/36248841
http://dx.doi.org/10.3389/fimmu.2022.991091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9556668/
https://www.ncbi.nlm.nih.gov/pubmed/36248841
http://dx.doi.org/10.3389/fimmu.2022.991091

Ejemplares similares